---
schema_version: "secwatch.filing_event.v1"
accession: "0001731122-25-000037"
form_type: "8-K"
ticker: "LNAI"
cik: "0001527728"
company_name: "Lunai Bioworks Inc."
filed_at: "2025-01-07T23:59:59+00:00"
generated_at: "2026-05-28T08:25:44.092692+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Renovaro signs binding LOI to buy Predictive Oncology; preferred stock valued at $3/share

## Summary
- POAI shareholders to receive new Renovaro preferred stock in 1:1 exchange; preferred stock redeemable at $3.00 per share after 18 months.
- Deal conditions include minimum $15M fundraising by Renovaro and POAI shareholder approval; definitive agreement due by Feb 28, 2025.
- If POAI warrants not exercised by Jan 15, Renovaro will buy up to 2.33M POAI common shares at $1.07 each.
- Transaction provides access to POAI's biobank of 150,000 tumor specimens and AI platform with 92% drug-response accuracy.
- Combined entity aims to launch decision-support platform for oncologists in 2025, integrating multi-omic diagnostics and drug discovery.

## SEC filing metadata
- accession: 0001731122-25-000037
- form_type: 8-K
- ticker: LNAI
- cik: 0001527728
- company_name: Lunai Bioworks Inc.
- filed_at: 2025-01-07T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1527728/000173112225000037/0001731122-25-000037-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1527728/000173112225000037/e6266_8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001731122-25-000037
- JSON: https://secwatch.observer/filing/0001731122-25-000037.json
- Plain text: https://secwatch.observer/filing/0001731122-25-000037.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.